T. Rowe Price Associates’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$812K Buy
11,276
+900
+9% +$51.2K ﹤0.01% 2244
2025
Q4
$439K Sell
10,376
-1,600
-13% -$89.5K ﹤0.01% 2453
2025
Q3
$682K Sell
11,976
-5,822
-33% -$193K ﹤0.01% 2244
2025
Q2
$460K Buy
17,798
+706
+4% +$7.93K ﹤0.01% 2345
2025
Q1
$175K Buy
17,092
+4,227
+33% +$55.2K ﹤0.01% 2696
2024
Q4
$180K Buy
12,865
+729
+6% +$12.9K ﹤0.01% 2724
2024
Q3
$237K Hold
12,136
﹤0.01% 2581
2024
Q2
$226K Buy
12,136
+3,819
+46% +$80.5K ﹤0.01% 2544
2024
Q1
$117K Hold
8,317
﹤0.01% 2753
2023
Q4
$71K Hold
8,317
﹤0.01% 2763
2023
Q3
$75K Buy
8,317
+3,874
+87% +$37.3K ﹤0.01% 2712
2023
Q2
$39K Sell
4,443
-14,735
-77% -$157K ﹤0.01% 2828
2023
Q1
$203K Buy
19,178
+1,986
+12% +$60.1K ﹤0.01% 2520
2022
Q4
$583K Sell
17,192
-250
-1% -$12.1K ﹤0.01% 2063
2022
Q3
$838K Sell
17,442
-1,175
-6% -$69.9K ﹤0.01% 1849
2022
Q2
$1.06M Buy
18,617
+11,685
+169% +$737K ﹤0.01% 1870
2022
Q1
$560K Buy
6,932
+669
+11% +$99K ﹤0.01% 2287
2021
Q4
$1.27M Sell
6,263
-2,180
-26% -$473K ﹤0.01% 1911
2021
Q3
$2.27M Sell
8,443
-25,821
-75% -$6.21M ﹤0.01% 1675
2021
Q2
$8.82M Sell
34,264
-1,214
-3% -$336K ﹤0.01% 1432
2021
Q1
$10.6M Sell
35,478
-1,115
-3% -$347K ﹤0.01% 1385
2020
Q4
$9.33M Sell
36,593
-37,958
-51% -$9.81M ﹤0.01% 1357
2020
Q3
$18.6M Sell
74,551
-11,542
-13% -$3.63M ﹤0.01% 1173
2020
Q2
$29.9M Sell
86,093
-7,548
-8% -$2.36M ﹤0.01% 1015
2020
Q1
$25.1M Buy
93,641
+27,971
+43% +$8.65M ﹤0.01% 997
2019
Q4
$21.3M Sell
65,670
-32,284
-33% -$9.36M ﹤0.01% 1163
2019
Q3
$26.8M Buy
97,954
+9,719
+11% +$3.56M ﹤0.01% 1062
2019
Q2
$47.1M Sell
88,235
-4,863
-5% -$2.44M 0.01% 915
2019
Q1
$46.9M Sell
93,098
-8,983
-9% -$5.32M 0.01% 905
2018
Q4
$50.3M Sell
102,081
-16,202
-14% -$9.78M 0.01% 817
2018
Q3
$108M Sell
118,283
-10,002
-8% -$8.54M 0.02% 647
2018
Q2
$94M Sell
128,285
-82,264
-39% -$94.9M 0.01% 681
2018
Q1
$336M Buy
210,549
+87,174
+71% +$112M 0.05% 346
2017
Q4
$111M Buy
123,375
+44,908
+57% +$26.6M 0.02% 612
2017
Q3
$28.2M Buy
78,467
+11,832
+18% +$3.7M ﹤0.01% 1065
2017
Q2
$19.5M Sell
66,635
-19,182
-22% -$5.54M ﹤0.01% 1181
2017
Q1
$30.2M Buy
85,817
+4,570
+6% +$1.03M 0.01% 994
2016
Q4
$15M Buy
81,247
+4,154
+5% +$845K ﹤0.01% 1226
2016
Q3
$19.9M Buy
77,093
+38,126
+98% +$9.82M ﹤0.01% 1131
2016
Q2
$8.32M Buy
38,967
+7,040
+22% +$1.57M ﹤0.01% 1319
2016
Q1
$6.58M Buy
31,927
+3,447
+12% +$662K ﹤0.01% 1344
2015
Q4
$7.2M Buy
28,480
+3,267
+13% +$672K ﹤0.01% 1354
2015
Q3
$4.14M Buy
25,213
+600
+2% +$106K ﹤0.01% 1462
2015
Q2
$4.62M Sell
24,613
-327
-1% -$56.3K ﹤0.01% 1496
2015
Q1
$4.12M Sell
24,940
-3,454
-12% -$710K ﹤0.01% 1498
2014
Q4
$6.6M Buy
28,394
+5,507
+24% +$1.18M ﹤0.01% 1424
2014
Q3
$4.14M Buy
22,887
+787
+4% +$151K ﹤0.01% 1485
2014
Q2
$4.25M Sell
22,100
-70,793
-76% -$12.5M ﹤0.01% 1478
2014
Q1
$16.9M Sell
92,893
-2,907
-3% -$575K ﹤0.01% 1161
2013
Q4
$16.3M Buy
95,800
+733
+0.8% +$118K ﹤0.01% 1148
2013
Q3
$14.9M Sell
95,067
-5,860
-6% -$1.08M ﹤0.01% 1164
2013
Q2
$17.5M Buy
+100,927
New +$15.5M ﹤0.01% 1101

Other funds holding NKTR